Evonik announced today that it entered into an agreement with AMSilk to produce sustainable silk proteins.
AMSilk, a Germany-based biotech company, develops innovative, sustainable silk proteins. The uses of the silk include a broad range of applications including medical devices. They provide optimal performance and minimal environmental impact, according to a news release.
Essen, Germany-based Evonik’s agreement covers the production of industrial quantities of the silk proteins. Evonik plans to produce the silk at its contract development and manufacturing (CDMO) precision fermentation site in Slovakia.
“Working with a partner who puts sustainability at the heart of their business is in perfect alignment with our goals at Evonik. We are delighted to partner with AMSilk to bring smart biotech silk materials to industries worldwide,” said Thomas Riermeier, head of the Health Care business line at Evonik.
AMSilk turns man-made proteins into …